Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909358What this trial is testingSolidarity/Tokomeza Ebola TrialWho this might be right forSudan Ebola Virus Vaccines Makerere University 2,121
Not applicableUnknownNCT05868551What this trial is testingOnchocerciasis-Associated Epilepsy, an Explorative Case-control StudyWho this might be right forOnchocercal Subcutaneous NoduleEpilepsyVirus Universiteit Antwerpen 40
Early research (Phase 1)Looking for participantsNCT07565090What this trial is testingA Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General HealthWho this might be right forSudan Virus Disease International AIDS Vaccine Initiative 112
Not applicableStudy completedNCT07205848What this trial is testingEvaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing CrisesWho this might be right forDengue Hemorrhagic FeverAwareness Research and Publication office 164
Not applicableStudy completedNCT07750834What this trial is testingImplementation and Assessment of a Medication Therapy Management Program in HIV Patients at High Risk of Adverse Drug Events at Khartoum, SudanWho this might be right forHIV Infections Universiti Sains Malaysia 1,149
Early research (Phase 1)UnknownNCT05301504What this trial is testingA Study in Tanzania of a New Vaccine Against Two Types of EbolaWho this might be right forEbola University of Oxford 76
Large-scale testing (Phase 3)UnknownNCT04381871What this trial is testingPotential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 PatientsWho this might be right forCOVID 19 Al-Neelain University 110
Not applicableStudy completedNCT04568499What this trial is testingPresenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian SettingsWho this might be right forCOVID-19 Johns Hopkins Bloomberg School of Public Health 592
Early research (Phase 1)Study completedNCT05079750What this trial is testingA New Vaccine Against Two Types of EbolaWho this might be right forEbola University of Oxford 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06803342What this trial is testingA Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy AdultsWho this might be right forEbola Sudan Virus Disease Albert B. Sabin Vaccine Institute 200
Early research (Phase 1)Study completedNCT04723602What this trial is testingEvaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsWho this might be right forEbola Virus DiseaseMarburg Virus Disease Albert B. Sabin Vaccine Institute 32
Testing effectiveness (Phase 2)Study completedNCT06036602What this trial is testingMonovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy AdultsWho this might be right forEbola Sudan Virus Disease Albert B. Sabin Vaccine Institute 125
Early research (Phase 1)Study completedNCT04041570What this trial is testingEbola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy AdultsWho this might be right forEbola Virus National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT05724472What this trial is testingEvaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General HealthWho this might be right forEbola Sudan Virus Disease International AIDS Vaccine Initiative 36